Researchers challenge testosterone fears, page-3

  1. 494 Posts.
    That was also a sig problem with the Vigen et al 2013 research - it was an observational study and because of this had a very poor control over the subjects etc. Less than 60% has followup blood tests and sig difference in the baseline levels between the measured groups....

    Also in that study - only 1.1% of the population were prescribed testosterone gel... the rest patches and injections...

    still to read the other research report in full so will be interesting to see what the detail/issues is in this one too.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.8¢
Change
-0.001(5.26%)
Mkt cap ! $7.339M
Open High Low Value Volume
1.9¢ 1.9¢ 1.8¢ $11.58K 619.2K

Buyers (Bids)

No. Vol. Price($)
4 335415 1.8¢
 

Sellers (Offers)

Price($) Vol. No.
1.9¢ 516258 1
View Market Depth
Last trade - 16.10pm 23/06/2025 (20 minute delay) ?
ACR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.